CLINICAL_TRIALS
trial_result
· 2024-03-22
Clinical Trial Update: Two Doses of the Intravenous Magnesium Sulfate Versus the Standard Single Dose ,With/ Without the Nebulized Budesonide For the Management of the Severe Asthma Exacerbation in the Emergency Room; A Randomized Controlled Trial. [Phase 3]
Summary
Phase 3 randomized controlled trial evaluating two intravenous magnesium sulfate doses (vs standard single dose) with or without nebulized budesonide for severe…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hamad Medical Corporation | Conditions: Bronchial Asthma | Phase 3 | Status: UNKNOWN